• The study included 141 patients with confirmed BE and 138 control patients.
• The study compared three different risk models. The first was based only on GERD frequency and duration. The second included GERD frequency and duration, age, sex, race, waist-to-hip ratio and H. pylori status. The third included all of the variables of the second model, as well as a multibiomarker risk score.
• The multibiomarker risk score was based on serum levels of interleukin (IL) 12p70, IL6, IL8, IL10 and leptin.
• Patients with a multibiomarker risk score of three or higher, in comparison to patients with a score of zero, had a 10-fold increased risk for BE.
• The study authors concluded that the addition of a multibiomarker risk score to previous methods may be more accurate than previous methods alone.
More Articles on Gastroenterology:
Best ideas for entrepreneurial gastroenterologists: Public presence, ASC ownership & more
10 must-reads on colonoscopy & colorectal cancer screening
New GI technology on the scene: 5 devices receive FDA 510(k) clearance in July
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.